Evidence map›Paper›PMID 35835695›Full record

ArticleImmunology2022

Pneumolysin suppresses the initial macrophage pro-inflammatory response to Streptococcus pneumoniae.

Jimstan Periselneris, Carolin T Turner, Giuseppe Ercoli, Gabriella Szylar, Caroline M Weight, Teresa Thurston, Matthew Whelan, Gillian Tomlinson, Mahdad Noursadeghi, Jeremy Brown

Open access · hybridAbstract read
In one paragraph

Article in Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jimstan PeriselnerisCentre for Inflammation and Tissue Repair, Division of Medicine, University College Medical School, London, UK.ORCID 0000-0001-9377-3077
Carolin T TurnerDivision of Infection and Immunity, University College London, London, UK.
Giuseppe ErcoliCentre for Inflammation and Tissue Repair, Division of Medicine, University College Medical School, London, UK.
Gabriella SzylarCentre for Inflammation and Tissue Repair, Division of Medicine, University College Medical School, London, UK.
Caroline M WeightDivision of Infection and Immunity, University College London, London, UK.
Teresa ThurstonMRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, UK.
Matthew WhelanDivision of Infection and Immunity, University College London, London, UK.
Gillian TomlinsonDivision of Infection and Immunity, University College London, London, UK.
Mahdad NoursadeghiDivision of Infection and Immunity, University College London, London, UK.
Jeremy BrownCentre for Inflammation and Tissue Repair, Division of Medicine, University College Medical School, London, UK.
University College London · GBCentre for Inflammation Research · GBImperial College London · GB

Funding

Medical Research Council G0700569Medical Research Council MR/K00168X/1Medical Research Council MR/R001871/1Wellcome Trust 106846/Z/15/ZWellcome Trust 207511/Z/17/Z
6 · The paper itself

Abstract

Published data for the Streptococcus pneumoniae virulence factor Pneumolysin (Ply) show contradictory effects on the host inflammatory response to infection. Ply has been shown to activate the inflammasome, but also can bind to MRC-1 resulting in suppression of dendritic cell inflammatory responses. We have used an in vitro infection model of human monocyte-derived macrophages (MDM), and a mouse model of pneumonia to clarify whether pro- or anti-inflammatory effects dominate the effects of Ply on the initial macrophage inflammatory response to S. pneumoniae, and the consequences during early lung infection. We found that infection with S. pneumoniae expressing Ply suppressed tumour necrosis factor (TNF) and interleukin-6 production by MDMs compared to cells infected with ply-deficient S. pneumoniae. This effect was independent of bacterial effects on cell death. Transcriptional analysis demonstrated S. pneumoniae expressing Ply caused a qualitatively similar but quantitatively lower MDM transcriptional response to S. pneumoniae compared to ply-deficient S. pneumoniae, with reduced expression of TNF and type I IFN inducible genes. Reduction of the MDM inflammatory response was prevented by inhibition of SOCS1. In the early lung infection mouse model, the TNF response to ply-deficient S. pneumoniae was enhanced and bacterial clearance increased compared to infection with wild-type S. pneumoniae. Overall, these data show Ply inhibits the initial macrophage inflammatory response to S. pneumoniae, probably mediated through SOCS1, and this was associated with improved immune evasion during early lung infection.

Indexed as

InflammasomesStreptococcus pneumoniaeAnimalsAnti-Inflammatory AgentsBacterial ProteinsHumansInterleukin-6MacrophagesMiceStreptolysinsTumor Necrosis FactorsVirulence FactorsAnti-Inflammatory AgentsBacterial ProteinsInflammasomesInterleukin-6plY protein, Streptococcus pneumoniaeStreptolysinsTumor Necrosis FactorsVirulence Factorsepithelial immunityinflammationpneumolysinStreptococcus pneumoniae

Identifiers

PMID35835695
PMCPMC10497322
OpenAlexW4285494400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.